Where can APAC add the most value to your oncology program?
Join experts to explore:
- Market selection: Evaluating Australia, China, Korea, Japan and other APAC markets to determine where the region can add the most value to an oncology program.
- Global development strategy: Designing early clinical programs to generate evidence that supports global development objectives and enhances asset value.
- Regulatory considerations: Exploring evolving regulatory pathways that may facilitate APAC integration into global programs and key considerations for navigating regional requirements.
Speakers:
- Jiamin Zhuo, Cofounder of ISWT community, and Director, Global Strategy Insight at EMD Serono
- Renita Hite, Director Regulatory, Novotech
- Tanja Obradovic, PhD, Vice President, Medical & Scientific Strategy, Oncology, Novotech